Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lane Rosen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Tumori|July 27, 2011
TomoTherapy stereotactic body radiation therapy (SBRT) for the salvage treatment of locally recurrent esophageal adenocarcinoma following trimodality therapy: a case reportJames Kyle Russo, Lane Rosen
Anticancer Research|May 29, 2017
Effect of Radiation Therapy on Survival in Hodgkin's Lymphoma: A SEER Data AnalysisSamip Master, Nebu Koshy, Ben Wilkinson, et al.
Journal of Medical Imaging and Radiation Oncology|April 29, 2014
Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motionDrexell Hunter Boggs, Steven Feigenberg, Robert Walter, et al.
Radiation Oncology (London, England)|January 13, 2017
Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate casesAngelia Tran, Jingjing Zhang, Kaley Woods, et al.
Clinical and Translational Radiation Oncology|November 18, 2020
Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registryJames E Han, John Chang, Lane Rosen, et al.
Clinical and Translational Radiation Oncology|October 26, 2019
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Clinical and Translational Radiation Oncology|April 8, 2020
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Advances in Radiation Oncology|October 14, 2021
Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 TrialJacob S Parzen, Michael D Chuong, John Chang, et al.
Advances in Radiation Oncology|January 24, 2022
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective RegistryAurélien Jongen, Florian Charlier, Kelsey Baker, et al.
American Journal of Clinical Oncology|April 14, 2021
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG GuidelinesYolanda D Tseng, Mark Pankuch, Pranshu Mohindra, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Tumori|July 27, 2011
TomoTherapy stereotactic body radiation therapy (SBRT) for the salvage treatment of locally recurrent esophageal adenocarcinoma following trimodality therapy: a case reportJames Kyle Russo, Lane Rosen
Anticancer Research|May 29, 2017
Effect of Radiation Therapy on Survival in Hodgkin's Lymphoma: A SEER Data AnalysisSamip Master, Nebu Koshy, Ben Wilkinson, et al.
Journal of Medical Imaging and Radiation Oncology|April 29, 2014
Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motionDrexell Hunter Boggs, Steven Feigenberg, Robert Walter, et al.
Radiation Oncology (London, England)|January 13, 2017
Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate casesAngelia Tran, Jingjing Zhang, Kaley Woods, et al.
Clinical and Translational Radiation Oncology|November 18, 2020
Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registryJames E Han, John Chang, Lane Rosen, et al.
Clinical and Translational Radiation Oncology|October 26, 2019
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Clinical and Translational Radiation Oncology|April 8, 2020
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Advances in Radiation Oncology|October 14, 2021
Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 TrialJacob S Parzen, Michael D Chuong, John Chang, et al.
Advances in Radiation Oncology|January 24, 2022
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective RegistryAurélien Jongen, Florian Charlier, Kelsey Baker, et al.
American Journal of Clinical Oncology|April 14, 2021
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG GuidelinesYolanda D Tseng, Mark Pankuch, Pranshu Mohindra, et al.
Pageof 2